Jue Pu
Directeur/Membre du Conseil chez LEPU BIOPHARMA CO., LTD.
Fortune : 63 M $ au 30/04/2024
Profil
Jue Pu was the founder of CG Oncology, Inc. founded in 2010, where he held the title of Director from 2010 to 2018.
He is currently a Director at Inspirna, Inc. since 2018 and a Non-Executive Director at Lepu Biopharma Co., Ltd.
since 2020.
Mr. Pu was also a Director at CG Oncology, Inc. from 2019 to 2023.
Mr. Pu received his graduate degree from Stanford University in 2013 and his undergraduate degree from The Wharton School of the University of Pennsylvania in 2012.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 90 000 000 ( 5,61% ) | 63 M $ | 30/04/2024 |
Postes actifs de Jue Pu
| Sociétés | Poste | Début |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Directeur/Membre du Conseil | 22/04/2020 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/10/2018 |
Anciens postes connus de Jue Pu
| Sociétés | Poste | Fin |
|---|---|---|
| CG ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/10/2023 |
| CG ONCOLOGY, INC. | Fondateur | 01/01/2018 |
Formation de Jue Pu
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
